comparemela.com

Latest Breaking News On - Serhat unal - Page 1 : comparemela.com

Sinovac found to have 83 5% efficacy in Turkey

Sinovac found to have 83.5% efficacy in Turkey China Daily | Updated: 2021-03-05 09:47 Serhat Unal (right) and Murat Akova of Ankara s Hacettepe University announce the findings of phase III trials of Sinovac s COVID-19 vaccine on Wednesday. RASIT AYDOGAN/GETTY IMAGES ISTANBUL-A COVID-19 vaccine made by Chinese drugmaker Sinovac Biotech has an efficacy of 83.5 percent based on phase III trials in Turkey, a Turkish university said on Wednesday. The results were based on 10,216 participants aged 18-59, 3,568 of whom had received a placebo as part of the trials that began in mid-September, said Serhat Unal, a medical faculty member of the Department of Infectious Diseases and Clinical Microbiology at Ankara s Hacettepe University, and a member of Turkey s Coronavirus Scientific Advisory Board.

AP Story

AP Story
talkradio1170.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkradio1170.com Daily Mail and Mail on Sunday newspapers.

World Insights: Turkey s confidence in China-developed COVID-19 vaccine strengthens - China News

2021-03-05 04:35:50 GMT2021-03-05 12:35:50(Beijing Time) Xinhua English ANKARA, March 5 (Xinhua) Turkey announced on Wednesday that the China-developed Sinovac vaccine has an efficacy of 83.5 percent against COVID-19, furthering the country s confidence in winning the fight against the pandemic. The CoronaVac shot developed by Sinovac Biotech was 100 percent effective in preventing hospitalization, according to the Phase-3 trials by the Hacettepe University in Ankara, the semi-official Anadolu Agency reported. No major side effects have been reported, professor Murat Akova from the university who led the trials, told reporters during a press conference. He added that the antibody levels were predicted to reach their maximum between 14 and 28 days after the second dose.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.